RFG
TEVA icon

RFP Financial Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

RFP Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-336
Closed -$5.46K – 718
2024
Q2 		$5.46K Sell
336
-28
-8% -$431 ﹤0.01% 544
2024
Q1 		$5.14K Buy
364
+245
+206% +$3.09K ﹤0.01% 524
2023
Q4 		$1.24K Hold
119
– – ﹤0.01% 750
2023
Q3 		$1.21K Hold
119
– – ﹤0.01% 748
2023
Q2 		$896 Hold
119
– – ﹤0.01% 837
2023
Q1 		$1.05K Hold
119
– – ﹤0.01% 629
2022
Q4 		$1.08K Buy
+119
New +$1.04K ﹤0.01% 762

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

RFP Financial Group's TEVA Position: Q3 2024 in Review

RFP Financial Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2024, closing a stake of 336 shares — an estimated $5.46K sold.

RFP Financial Group first reported a position in TEVA in Q4 2022 and held it in 7 quarters. The position peaked at $5.46K in Q2 2024. 544 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • RFP Financial Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 336 Teva Pharmaceutical Industries Limited shares in Q3 2024, an estimated $5.46K.
  • RFP Financial Group first reported a position in Teva Pharmaceutical Industries Limited in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Teva Pharmaceutical Industries Limited position peaked at $5.46K in Q2 2024.
  • 544 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.